Angiopep-2 modified PEGylated 2-methoxyestradiol micelles to treat the PC12 cells with oxygen-glucose deprivation/reoxygenation
Angiopep-2 modified PEGylated 2-methoxyestradiol micelles to treat the PC12 cells with oxygen-glucose deprivation/reoxygenation
复制标题
Angiopep-2 修饰的聚乙二醇化 2-甲氧基雌二醇胶束通过氧-葡萄糖剥夺/复氧处理 PC12 细胞
DOI:
10.1016/j.colsurfb.2018.08.009
复制
发表时间:
2018-11-01
影响因子:
5.8
通讯作者:
Guo, Shengrong
中科院分区:
文献类型:
--
作者:
Hu, Lijun;Wang, Yun;Guo, Shengrong
2-Methoxyestradiol (2ME2), as a microtubule and hypoxia-inducible factor-1 (HIP-1) inhibitor, can be used to treat cerebral ischemia-reperfusion (I/R) injury. However, its poor water solubility compromises its efficacy as a neuroprotectant. Herein, we synthesized PEGylated 2ME2 and angiopep-2 capped PEGylated 2ME2 and fabricated angiopep-2 modified PEGylated 2ME2 micelles containing free 2ME2 (ANG-PEG-2ME2/2ME2) via emulsion-solvent evaporation method. The effect of the micelles on ischemia-reoxygenation injury was evaluated by oxygen-glucose deprivation/reoxygenation (OGD/R) models with different degrees of PC12 cell damage. In comparison with free 2ME2, the micelles significantly increased the cell viability, inhibited reactive oxygen species (ROS) generation and apoptosis for PC12 cells with 0.5 and 4 h OGD followed by 24 h reoxygenation. Taken together, the angiopep-2 modified 2ME2-loaded micelles could effectively reduce the injury of PC12 cells induced by OGD/R.